Drug intelligence / Profile preview

MDrelief

Development stage: Unknown
Lead developer: MDbio Wellness
Administration: Oral

Overview

**MDrelief** is a botanical dietary supplement designed for pain relief and supporting healthy inflammation response. It contains a blend of natural ingredients including full-spectrum hemp, white willow bark, frankincense, and other herbs. It is marketed as a natural alternative to NSAIDs for managing occasional pain and supporting joint and muscle health by activating the endocannabinoid system.

Brand names: MDreliefMDrelief Botanical Blend

Beyond the preview

Go deeper on MDrelief.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDrelief.

Explore the full profile